Emory Sayre De Castro - Feb 6, 2023 Form 4/A - Amendment Insider Report for ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN)

Signature
/s/ Emory Sayre De Castro
Stock symbol
ADN
Transactions as of
Feb 6, 2023
Transactions value $
-$60,686
Form type
4/A - Amendment
Date filed
4/14/2023, 04:45 PM
Date Of Original Report
Feb 7, 2023
Previous filing
Feb 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADN Common Stock Sale -$15.2K -7.6K -0.31% $2.00 2.44M Feb 6, 2023 Direct F1, F2
transaction ADN Common Stock Sale -$27.4K -14K -0.57% $1.96 2.42M Feb 7, 2023 Direct F1, F3
transaction ADN Common Stock Sale -$18.1K -9.25K -0.38% $1.96 2.41M Feb 8, 2023 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Aggregate number of shares sold on the same date at different prices. Shares sold by Reporting Person solely to satisfy income tax and withholding and remittance obligations in connection with the vesting and net settlement of Restricted Stock Units.
F2 Weighted average sale price. The shares were sold in multiple transactions at prices ranging from $1.974963 to $2.05, inclusive. Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission (the "Staff"), upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3 Weighted average sale price. The shares were sold in multiple transactions at prices ranging from $1.93497 to $1.99499, inclusive. Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the Staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F4 Weighted average sale price. The shares were sold in multiple transactions at prices ranging from $1.90655 to $1.945296, inclusive. Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the Staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Remarks:

This Form 4 amendment is being filed to correct inadvertent errors in the Form 4 filed by Reporting Person on February 7, 2023.